Altimmune, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of Altimmune, Inc.'s 2021 Annual Meeting of Stockholders held on September 23, 2021. As of the record date (August 10, 2021), there were 39,705,884 shares of common stock outstanding. A quorum was established with 28,489,957 shares (71.75%) present or represented by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal No. 1 (Election of Directors): All eight nominees were elected. Notable vote splits included John M. Gill (11,033,020 For vs. 7,779,479 Withhold) and Wayne Pisano (14,848,010 For vs. 3,964,489 Withhold). Other directors received significantly higher support.
- Proposal No. 2 (Ratification of Auditors): The appointment of Ernst & Young LLP was ratified with 28,430,498 votes For, 29,266 Against, and 30,193 Abstain.
- Proposal No. 3 (Say-on-Pay): The advisory vote on executive compensation was rejected. Results were 8,321,213 For, 10,439,681 Against, and 51,605 Abstain.
- Proposal No. 4 (Adjournment): The proposal to authorize adjournment to solicit additional proxies was approved with 18,509,254 For, 9,785,811 Against, and 194,892 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the voting outcomes.
Key Facts for Investor Verification
- Stockholders rejected the "say-on-pay" proposal, indicating dissatisfaction with executive compensation.
- Two directors (John M. Gill and Wayne Pisano) received significant "Withhold" votes compared to their peers.
- The company successfully ratified its independent auditor and elected its full slate of directors.
- Broker non-votes were significant (9,677,458 shares) for the director election and say-on-pay proposals.